Browse Category

NASDAQ:KALA News 4 December 2025 - 5 December 2025

KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update

KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update

KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the most volatile biotech penny stocks on the market in late 2025. After a failed eye‑disease trial, a loan default and a near‑miss with foreclosure, the company is now trying to recapitalize itself with fresh equity and new leadership. On December 4, 2025, KALA BIO announced a $10 million registered direct offering of common stock at $1.00 per share, the latest in a series of emergency financings and debt negotiations that have whipsawed KALA stock and left existing shareholders heavily diluted. Finviz+4GlobeNewswire+4GlobeNewswire+4 At the same time, new CEO David E.
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

As of December 4, 2025, KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the wildest tickers on the Nasdaq. The stock is trading around $1.40 in heavy volume, up roughly 50% on the day after a cascade of news: a $10 million registered direct offering, a loan settlement that turns lender Oxford Finance into a 16.5% shareholder, and a $6 million rescue-style preferred investment from new CEO David Lazar. All this arrives barely two months after KALA’s lead drug failed a key trial, its lender swept most of its cash, and management warned of “substantial doubt” about its

Stock Market Today

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Go toTop